Riley Brigit 4
4 · Adverum Biotechnologies, Inc. · Filed Sep 21, 2022
Insider Transaction Report
Form 4
Riley Brigit
Chief Scientific Officer
Transactions
- Sale
Common Stock
2022-09-19$1.07/sh−7,266$7,772→ 118,734 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain performance stock units.
- [F2]Price reported is a weighted-average sale price. The shares were sold at prices ranging from $1.069589 to $1.075. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes 6,000 shares purchased on May 20, 2022 pursuant to the Issuer's 2014 Employee Stock Purchase Plan, as amended and restated.